Search clinical trials for: pertuzumab [Perjeta]
Total 461 results
-
Shanghai Henlius BiotechCompletedHealthy Male VolunteersChina
-
Zydus Lifesciences LimitedNot yet recruiting
-
BiocadRecruitingBreast CancerRussian Federation
-
BiocadActive, not recruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Roche Pharma AGCompletedEsophageal CarcinomaNetherlands
-
Mabscale, LLCActive, not recruitingHealthy MenRussian Federation
-
Hoffmann-La RocheCompletedBreast CancerKorea, Republic of
-
Istituto Oncologico Veneto IRCCSAssociation for Translational Research in Oncology (AS.T.R.O.)CompletedEndocrine Sensitive HER2+/HR+ Breast CancerItaly
-
Hoffmann-La RocheTerminatedProstate CancerSpain, United Kingdom, France, Germany, Italy, Netherlands
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast CancerUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingColorectal Neoplasms | Ovarian Neoplasms | Solid Tumor | Gallbladder Neoplasms | Prostatic Neoplasm | Pancreatic Neoplasm | Lung Neoplasm | Haematological Malignancy | Urinary Bladder Neoplasm | Skin Neoplasm | Salivary Gland NeoplasmUnited Kingdom
-
Hoffmann-La RocheCompletedBreast CancerCanada, Spain, France, United Kingdom, Italy
-
Helsinki University Central HospitalActive, not recruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
EirGenix, Inc.Sacura GmbHCompleted
-
Genentech, Inc.Completed
-
Hoffmann-La RocheCompleted
-
Kimberly BlackwellTerminatedHER2 Positive Untreated Metastatic Breast Cancer | Asymptomatic or Low Symptomatic Brain Metastasis in Breast CancerUnited States
-
Peking University Cancer Hospital & InstituteRecruitingHER2-positive Metastatic Breast Cancer | Previously Treated With Trastuzumab | Trastuzumab Combined With Pertuzumab and ChemotherapyChina
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdCompletedSimilarity of Pharmacokinetics and SafetyChina
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
AC Camargo Cancer CenterRecruitingBreast Neoplasms | HER2-positive Breast Cancer | Circulating Tumor CellBrazil
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
Queen Mary University of LondonGilead SciencesUnknownRecurrent or Refractory B Cell Acute Lymphoblastic LeukaemiaUnited Kingdom
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Hoffmann-La RocheActive, not recruitingSolid TumorKorea, Republic of, China, France, Portugal, Spain, Brazil, Germany, Italy, Peru, Russian Federation, Japan, Ukraine, Costa Rica, Mexico, Poland
-
The Methodist Hospital Research InstituteAstraZenecaRecruitingBreast CancerUnited States
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruitingMetastatic Breast CancerSpain
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline; Genentech, Inc.; Susan G. Komen Breast Cancer FoundationCompleted
-
Hoffmann-La RocheCompletedBreast CancerHungary, Italy, Spain, France, United Kingdom, Belgium, Germany, Portugal, Poland, Canada, Bulgaria, Mexico
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.; Translational Breast Cancer Research ConsortiumActive, not recruitingBreast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerSpain, United Kingdom, Belgium, Austria, Brazil, France, Germany, Hungary, Italy, Thailand, Korea, Republic of, Hong Kong, Romania, Canada, Argentina, Czechia, Peru, Estonia, Mexico, Poland, Russian Federation, Croatia, Netherlands
-
Shanghai Henlius BiotechActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast CancerChina
-
West German Study GroupMerck Sharp & Dohme LLC; NanoString Technologies, Inc.Completed
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Genentech, Inc.Roche Pharma AGCompletedNon-Small Cell Lung CancerAustralia, United States
-
The Netherlands Cancer InstituteSeagen Inc.Recruiting
-
Hoffmann-La RocheCompletedGastric CancerFrance, Belgium, Korea, Republic of, Spain, Czechia, Germany, Italy, Netherlands
-
SCRI Development Innovations, LLCGenentech, Inc.; Prometheus LaboratoriesCompletedBreast CancerUnited States
-
Weill Medical College of Cornell UniversityGilead SciencesTerminatedFollicular LymphomaUnited States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerSpain, United Kingdom, Belgium
-
Dana-Farber Cancer InstituteSusan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation; Terri...Active, not recruiting
-
Genentech, Inc.Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Canada, China, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Spain, United Kingdom, Brazil, Guatemala, Japan, Russian Federation, Singapore, Thailand, Latvia, Argentina, Poland, Ecuador, Mexico, Croatia and more
-
Hoffmann-La RocheCompleted